Zacks
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
📈
AI Sentiment
Highly Positive
8/10
- Home
- IPSC
as of 12-15-2025 3:22pm EST
$0.58
+$0.02
+3.17%
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
Chart Type:
Time Range:
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | PHILADELPHIA |
| Market Cap: | 49.8M | IPO Year: | 2021 |
| Target Price: | $3.00 | AVG Volume (30 days): | 934.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.34 - $1.38 | Next Earning Date: | 11-13-2025 |
| Revenue: | $113,337,000 | Revenue Growth: | 4122.69% |
| Revenue Growth (this year): | 1590.09% | Revenue Growth (next year): | N/A |
AI-Powered IPSC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 68.46%
68.46%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Century Therapeutics Inc. (IPSC)
Russotti Gregory
Sell
See Remarks
IPSC Dec 8, 2025
Avg Cost/Share
$0.53
Shares
526
Total Value
$279.83
Owned After
390,982
SEC Form 4
Carr Douglas
Sell
SVP Finance & Operations
IPSC Dec 8, 2025
Avg Cost/Share
$0.53
Shares
257
Total Value
$136.72
Owned After
404,874
SEC Form 4
Cowan Chad
Sell
Chief Scientific Officer
IPSC Nov 20, 2025
Avg Cost/Share
$0.50
Shares
5,462
Total Value
$2,736.46
Owned After
987,027
SEC Form 4
Pfeiffenberger Brent
Buy
President and CEO
IPSC Nov 19, 2025
Avg Cost/Share
$0.50
Shares
35,000
Total Value
$17,328.50
Owned After
3,271,453
SEC Form 4
Pfeiffenberger Brent
Sell
President and CEO
IPSC Nov 17, 2025
Avg Cost/Share
$0.45
Shares
32,456
Total Value
$14,735.02
Owned After
3,236,453
SEC Form 4
Carr Douglas
Sell
SVP Finance & Operations
IPSC Nov 3, 2025
Avg Cost/Share
$0.59
Shares
292
Total Value
$171.11
Owned After
404,874
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Russotti Gregory | IPSC | See Remarks | Dec 8, 2025 | Sell | $0.53 | 526 | $279.83 | 390,982 | |
| Carr Douglas | IPSC | SVP Finance & Operations | Dec 8, 2025 | Sell | $0.53 | 257 | $136.72 | 404,874 | |
| Cowan Chad | IPSC | Chief Scientific Officer | Nov 20, 2025 | Sell | $0.50 | 5,462 | $2,736.46 | 987,027 | |
| Pfeiffenberger Brent | IPSC | President and CEO | Nov 19, 2025 | Buy | $0.50 | 35,000 | $17,328.50 | 3,271,453 | |
| Pfeiffenberger Brent | IPSC | President and CEO | Nov 17, 2025 | Sell | $0.45 | 32,456 | $14,735.02 | 3,236,453 | |
| Carr Douglas | IPSC | SVP Finance & Operations | Nov 3, 2025 | Sell | $0.59 | 292 | $171.11 | 404,874 |
Latest Century Therapeutics Inc. News
IPSC Breaking Stock News: Dive into IPSC Ticker-Specific Updates for Smart Investing
GlobeNewswire
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
📊
AI Sentiment
Positive
7/10
Compare IPSC vs Leading Stocks
See how IPSC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IPSC Century Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.